FENRIS BIO AS
Operating
Utvikle nye medisiner mot kroniske sykdommer.
Utvikling av ny medisin.
Organization
- CEO
- Chairman of the board
- ØR
Øivind Resch1961
- Years since formation
- 1 year
- since Mar 6, 2025
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Financials
- Annual total result 2025
- -1,452,890
- NOK
- Total equity 2025
- -628,458
- NOK
Last update: Jul 27, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
| Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
ØR 1961 | Chairman | - |
| Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Jun 19, 2025
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 0 |
Annual Total Result | -1,452,890 |
Total assets | 1,767,387 |
Total liabilities | 2,395,844 |
Total equity | -628,458 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 0 |
Total operating costs | 1,445,130 |
Operating result | -1,445,130 |
Financial income/costs | -7,759 |
Profit before tax | -1,452,890 |
Total tax & extraordinary income/cost | 0 |
Annual Total Result | -1,452,890 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 0 |
Total current assets | 1,767,387 |
Total assets | 1,767,387 |
Short term debt | 2,395,844 |
Long term debt | 0 |
Total liabilities | 2,395,844 |
Contributed capital | 824,432 |
Retained earnings | -1,452,890 |
Total equity | -628,458 |
Total equity and liabilities | 1,767,387 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises